QUBT Earnings Preview: The GF Value Claim Doesn't Survive the Peer Test

Quantum Computing reports Q2 earnings in three days. That's the deadline the market has set for deciding whether $8.93 is the floor or just a checkpoint on the way down.

Q1 was a beat. EPS came in at minus 2 cents versus an expected minus 5, and revenue jumped to $3.7 million from $39,000 a year earlier. That looks like growth until you notice the jump was engineered by spending $188 million on three acquisitions — Luminar Semiconductor for $110 million, NHanced Semiconductors for $73.1 million (with up to $72 million in contingent payments), and NuCrypt for $5 million. Revenue grew because the balance sheet grew. Operating expenses for that quarter were $19.8 million, more than five times the revenue. The underlying business economics haven't changed; the company's definition of "business" has just gotten more expensive.

The GF Value claim doesn't survive scrutiny.

The competitor article leans on GuruFocus's GF Value model showing a $10.51 fair value, implying roughly 20% upside from today's price. The problem is the model itself flags the conditions under which it becomes unreliable: early-stage growth companies, firms with unstable fundamentals, businesses undergoing major turnarounds, and companies with short public histories. QUBT matches all four. The GF Value methodology is built on historical correlations between price and fundamentals like revenue, earnings, cash flow, and book value. It assumes those historical patterns persist. For a company that has fundamentally changed its strategy, margin structure, and growth profile within a single quarter, that assumption is the weak link. GuruFocus's own GF Value page from August 2025 flagged the stock as "significantly overvalued" with a price-to-GF-Value ratio of 20 — the exact opposite conclusion. The $10.51 figure is a snapshot, not a signal. It is less useful than the price the market is actually paying today.

The real comparison set doesn't care about GF Value either.

QUBT trades at a $1.96 billion market cap on roughly $4.7 million in expected quarterly revenue. Annualized, that is approximately 418 times trailing sales. IonQ, the sector's largest pure-play, trades at a $15.4 billion market cap and 82 times trailing sales. That's still a premium, but IonQ has a revenue base more than ten times QUBT's, a commercial track record, and a profitability path that the market can actually score. QUBT's 418x revenue multiple means even exceptional execution — and there's no evidence the Fab 1 foundry will clear the gap between "early revenue" and commercial scale — doesn't narrow the valuation overhang fast enough to matter.

The technical picture reflects the repricing.

QUBT is trading below its 50-day simple moving average ($9.34) and its 200-day moving average ($10.05). The RSI sits at 53 — neutral, not oversold, which means there's no statistical bounce case. The stock fell from over $23 in mid-2025 to under $9 today. That 62% decline wasn't a sector event. It was a specific repricing of what the market believes QUBT can deliver with $1.4 billion in cash and a business model that still can't produce revenue at the speed its acquisition spending implies it should.

The Zacks consensus for Q2 estimates $4.7 million in revenue and a loss of 12 cents per share. Revenue is expected to grow 7,733% year-over-year. That number is technically accurate and functionally meaningless — it reflects the $39,000 base from Q1 2025, before any of the acquisitions closed. The more honest frame is $4.7 million versus $3.7 million last quarter, or 27% sequential growth, which is better but doesn't touch the $19.8 million quarterly operating expense base.

The contract backlog of $16 million provides some near-term visibility. Spread across a full year, it implies roughly $4 million in additional revenue — which would approximately double annual sales to $8–9 million. Against a $1.96 billion market cap, the backlog doesn't bridge the gap. Against a $1.4 billion cash hoard, it shows the company isn't running out of runway but also isn't finding its way to revenue at scale.

What would change the story?

A Q2 beat on both revenue and EPS that comes with a credible Fab 2 timeline and evidence that the Luminar and NHanced acquisitions are producing integrated revenue — not just stand-alone sales — would matter. The market needs to see the manufacturing thesis working, not the acquisition thesis. Every dollar spent on bolt-ons is a dollar not generating returns until integration is proven. A Q2 print that's in line with estimates or slightly below would confirm that the repricing is complete and the stock is now a deep speculative hold with a $1.4 billion cushion against near-term failure but no visible path to profitability that justifies the market cap.

The barbell approach here is straightforward. If you believe in quantum computing as a five-year theme, IonQ at $41 and Rigetti at $17 offer exposure with revenue bases that can actually be compared. If you're sitting in QUBT, the question isn't whether GF Value says you're 20% below fair value. It's whether $4.7 million in quarterly revenue and $16 million in backlog will convince the market that a $1.96 billion company is worth more than its burn rate. The August 10 print will give a partial answer. The factor stack won't confirm a bottom until revenue growth outpaces acquisition spending for at least two consecutive quarters.